Find Research Projects

Search results

• A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects with Erythropoietic Protoporphyria

  Anderson, K.

  Mitsubishi Tanabe Pharma

  6/6/18 → 6/5/23

  Project: Other project

• A Phase II, Single Arm, Open Label Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib - Study Drug AMN107

  Markowitz, A.

  Novartis Pharmaceuticals Corporation

  6/1/13 → 6/30/19

  Project: Other project

• A Phase IIa, two-part, randomised, multi-centre, multinational, double-blind, placebo-controlled, parallel group study to compare the efficacy and safety of BCT197 when added on to standard of care for the treatment of acute respiratory exacerbations o

  Calhoun, W.

  6/15/16 → 6/14/18

  Project: Other project

• A Phase IIa, two-part, randomised, multi-centre, multinational, double-blind, placebo-controlled, parallel group study to compare the efficacy and safety of BCT197 when added on to standard of care for the treatment of acute respiratory exacerbations o

  Calhoun, W.

  ICON Clinical Research LLC

  6/15/16 → 6/14/18

  Project: Other project

• A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)

  Gonzalez, E.

  EMD Serono Inc

  7/28/14 → 7/27/16

  Project: Other project

• A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)

  Gonzalez, E.

  7/28/14 → 7/27/16

  Project: Other project

• A Phase III, observer-blind, randomised, controlled, multi-centre study to evaluate the immunogenicity and safety of GSK Biologicals? quadrivalent influenza vaccine candidate, GSK2282512A (FLU Q-QIV), compared to Sanofi Pasteur?s quadrivalent influenza v

  Sarpong, K.

  GlaxoSmithKline Pharmaceuticals

  10/7/14 → 10/6/16

  Project: Other project

• A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO? when administered concomitantly with routine pe

  Rupp, R.

  Sanofi Pasteur Inc

  5/2/18 → 5/1/20

  Project: Other project

• A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when administered concomitantly with routine pe

  Rupp, R.

  5/2/18 → 5/1/21

  Project: Other project

• A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to

  Keiser, P.

  Merck Sharp & Dohme Corporation

  12/1/12 → 11/1/14

  Project: Other project

• A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to

  Keiser, P.

  12/1/12 → 11/1/14

  Project: Other project

• A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Immunogenicity of Three Consistency Lots and a high Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults

  Rupp, R.

  8/4/15 → 9/30/18

  Project: Other project

• A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Immunogenicity of Three Consistency Lots and a high Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults

  Rupp, R.

  Merck Sharp & Dohme Corporation

  8/4/15 → 9/30/18

  Project: Other project

• A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Heal

  Rupp, R.

  7/9/18 → 7/8/20

  Project: Other project

• A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Heal

  Rupp, R.

  Corixa Corporation

  7/9/18 → 7/8/20

  Project: Other project

• A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II

  Rupp, R.

  Merck Sharp & Dohme Corporation

  4/30/14 → 5/1/16

  Project: Other project

• A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II

  Rupp, R.

  4/30/14 → 5/1/16

  Project: Other project

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

  Khalife, W.

  Boehringer Ingelheim Pharmaceuticals

  10/17/17 → 10/16/20

  Project: Other project

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

  Khalife, W.

  10/17/17 → 10/16/21

  Project: Other project

• A Phase II Open Label Study to Assess the Efficacy and Safety of Gemcitabine & Nab-Paclitaxel (Abraxane With or Without OSHD (2-0, 3-0 Desulfated Heparin) as First Line Treatment of Metastatic Pancreatic Cancer

  Markowitz, A.

  ParinGenix Incorporated

  3/1/12 → 2/28/14

  Project: Other project

• A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naive and Flavivirus-Experienced Health Adults (MK-V181-001-01)

  Rupp, R.

  Merck Sharp & Dohme Corporation

  1/4/18 → 1/3/21

  Project: Other project

• A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naive and Flavivirus-Experienced Health Adults (MK-V181-001-01)

  Rupp, R.

  1/4/18 → 1/3/21

  Project: Other project

• A Phase I Randomized Clinical Trial of In-Hospital and Post-Hospital Whey Protein vs. Low Quality Protein vs. Isocaloric Placebo Supplementation to Improve Recovery From Hospitalization in Older Adults

  Volpi, E.

  2/1/18 → 3/1/22

  Project: Other project

• A Phase I Randomized Clinical Trial of In-Hospital and Post-Hospital Whey Protein vs. Low Quality Protein vs. Isocaloric Placebo Supplementation to Improve Recovery From Hospitalization in Older Adults

  Volpi, E.

  Dairy Management Inc.

  2/1/18 → 3/1/21

  Project: Other project

• A Phase ll, Randomized, Double-Blind, Placebo Controlled Bronchoscopy Study to Evaluate The Effects Of Lebrikizumab on Airway Eosinophilic Inflamation in Patients With Uncontrolled Asthma On Inhaled Corticosteroids and a Second Controller Medication

  Calhoun, W.

  5/28/14 → 5/15/18

  Project: Other project

• A Phase ll, Randomized, Double-Blind, Placebo Controlled Bronchoscopy Study to Evaluate The Effects Of Lebrikizumab on Airway Eosinophilic Inflamation in Patients With Uncontrolled Asthma On Inhaled Corticosteroids and a Second Controller Medication

  Calhoun, W.

  Genentech, Inc.

  5/28/14 → 5/15/18

  Project: Other project

• A point of care diagnostic test for the detection of SARS-CoV-2 antigen

  Aguilar, P.

  InBios International

  8/15/20 → 11/11/20

  Project: Other project

• APOL1 Long-Term Kidney Transplantation Outcomes-Consortium for the Responsible and Ethical Evaluation of Organ Donation (APOLLOCREED) Clinical Center

  Mujtaba, M.

  Johns Hopkins University

  4/1/19 → 5/31/20

  Project: Other project

• APOL1 Long-Term Kidney Transplantation Outcomes-Consortium for the Responsible and Ethical Evaluation of Organ Donation (APOLLOCREED) Clinical Center

  Mujtaba, M.

  4/1/19 → 5/31/20

  Project: Other project

• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity

  Mileski, W.

  University of Washington

  8/1/15 → 7/31/19

  Project: Other project

• A portable closed-loop fluid resuscitation system to promote critical care and warfighter survivability in the prolonged field care environment

  Kramer, G.

  TheraNova, LLC

  12/1/17 → 12/1/19

  Project: Other project

• A portable closed-loop fluid resuscitation system to promote critical care and warfighter survivability in the prolonged field care environment

  Kramer, G.

  12/1/17 → 12/1/19

  Project: Other project

• Application of Adipose-Derived Stem Cells as an Antiscarring Therapy Following Massive Burn Injuries

  Finnerty, C.

  9/30/18 → 10/24/18

  Project: Other project

• A Preclinical Model of Peripubertal and Adult Visceral Hypersensitivity

  Winston, J.

  National Inst of Diabetes & Digestive &

  9/18/18 → 8/31/21

  Project: Other project

• A Preclinical Model of Peripubertal and Adult Visceral Hypersensitivity

  Winston, J.

  9/18/18 → 8/31/21

  Project: Other project

• A prospective, single-arm, multicenter, uncontrolled, open-label Phase II trial of refametinib (BAY 86-9766) in patients with RAS mutant Hepatocellular Carcinoma (HCC)?

  Markowitz, A.

  Bayer HealthCare Pharmaceuticals

  7/30/13 → 12/31/16

  Project: Other project

• A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE PREDICTORS OF CLINICAL EFFECTIVENESS IN RESPONSE TO OMALIZUMAB

  Calhoun, W.

  Genentech, Inc.

  3/27/14 → 3/26/17

  Project: Other project

• A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE PREDICTORS OF CLINICAL EFFECTIVENESS IN RESPONSE TO OMALIZUMAB

  Calhoun, W.

  3/27/14 → 3/26/17

  Project: Other project

• A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0-3.0) plus

  Fujise, K.

  Boehringer Ingelheim Pharmaceuticals

  8/19/15 → 8/18/17

  Project: Other project

• A Prospetive Multicenter Phase lll Clinical Evaluation of the Safety and Efficacy of Lumason TM/SonoVue R In Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease

  Ahmad, M.

  Bracco Diagnostics

  8/11/15 → 3/31/20

  Project: Other project

• A Prospetive Multicenter Phase lll Clinical Evaluation of the Safety and Efficacy of Lumason TM/SonoVue R In Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease

  Ahmad, M.

  8/11/15 → 3/31/20

  Project: Other project

• APS ACTION INTERNATIONAL CLINICAL DATABASE AND REPOSITORY Protocol Number: AA01

  Gonzalez, E.

  Antiphospholipid Syndrome Action Network

  7/25/13 → 4/17/19

  Project: Other project

• APS ACTION INTERNATIONAL CLINICAL DATABASE AND REPOSITORY Protocol Number: AA01

  Gonzalez, E.

  7/25/13 → 4/17/19

  Project: Other project

• Apyrase Against Myocardial Reperfusion Injury

  Ye, Y.

  8/6/18 → 4/30/22

  Project: Other project

• Apyrase Against Myocardial Reperfusion Injury

  Ye, Y.

  AstraZeneca LP

  8/6/18 → 4/30/21

  Project: Other project

• A Qualitative Research Project to Document Community Opinions on Welcoming Central American Refugee Children into the Galveston County Community

  Raimer, B.

  Mary Moody Northen Endowment

  9/1/14 → 11/30/14

  Project: Other project

• A randomized, controlled trial comparing the immunogenicity of 2 doses vs 3 doses of the 9-valent HPV vaccine in males and females 15- 26 years of age

  Berenson, A.

  3/1/19 → 2/28/22

  Project: Other project

• A randomized, controlled trial comparing the immunogenicity of 2 doses vs 3 doses of the 9-valent HPV vaccine in males and females 15- 26 years of age

  Berenson, A.

  Cancer Prevention and Research Institute

  3/1/19 → 2/28/22

  Project: Other project

• A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis The Connection study

  Fonseca, R.

  10/24/19 → 10/23/22

  Project: Other project

• A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis The Connection study

  Fonseca, R.

  Infant Bacterial Therapeutics AB

  10/24/19 → 10/23/22

  Project: Other project